Qibiao Wu is an author at Harvard University.
Publications per year
2023–2024
2
2
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations
Eranga R. Balasooriya, Qibiao Wu, Haley Ellis et al. · Clinical Cancer Research · 2024 · 13 citations · Full text
Rows per page
1–2 of 2